Anna Kaltenboeck

Anna Kaltenboeck, M.A., M.B.A., is a principal and head of prescription drug reimbursement practice at ATI Advisory. A health economist, her work focuses on how federal and commercial reimbursement policies shape the market for prescription drugs and new health technologies. She provides federal and state-level technical assistance that is informed by her research and experience as a consultant specializing in pricing and market access for pharmaceutical products. Prior to joining ATI, Kaltenboeck was senior health advisor to the Senate Committee on Finance, where she led on drug pricing issues, including Medicare negotiation and prescription drug reimbursement provisions. Previously she was program director for the Center for Health Policy and Outcomes and the Drug Pricing Lab at Memorial Sloan Kettering Cancer Center. Kaltenboeck earned a B.A. and M.A. in economics from Tufts University and an M.B.A. from Yale University.